focus -WSS

focus

author：comprehensive 2025-09-06 06:16:47 - browse：568

European Medicines Agency Suffers Cyber Attack in Amsterdam — Paulo Amorim / VWPics via AP Images

LONDON — This week, European regulators are considering an appeal from Amylyx Pharmaceuticals after initially recommending against approving the company’s ALS treatment — the latest potential turning point for a drug that has seen its share of ups and downs with regulatory bodies.

In June, a European Medicines Agency committee issued a negative review of Amylyx’s drug, called Albrioza, and cast doubt on whether it had demonstrated effectiveness in its pivotal study. That would have almost certainly led to a rejection by regulators, but Amylyx requested what’s called a re-examination of the opinion. On Tuesday, the EMA held a meeting on the appeal, and a decision is expected in the coming weeks.

“There are patients who are dying and they really want access to the drug,” said Evy Reviers, the chairwoman of the European Organization for Professionals and Patients with ALS, whose father has the neurological disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： In his State of the Union, Biden takes clear aim at 'Big Pharma'

WSS

Just how do doctors, lawmakers, and the public define abortion?

How corporate America is slashing DEI workers amid backlash to diversity programs

IVF, abortion rights issues kick off Biden’s State of the Union

Sen. Paul opposes bill to ban Chinese biotechs

Change Healthcare cyberattack prompts Medicare loan program

The PBM ad wars are taking over Washington, D.C.

Wikipedia

focus

knowledge

Novavax promises a turnaround & Lilly roils the obesity market

How redistricting in 6 states could affect who controls Congress

Dobbs anniversary: the lost opportunity of abortion as health care

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

Supreme Court strikes down use of affirmative action

Another man arrested in connection with shooting at Kansas nightclub

As demand for Covid shots wanes, Moderna seeks its next success

Just how do doctors, lawmakers, and the public define abortion?

Hepatitis C has a cure — but many Americans still lack access to it

The Readout: Amylyx, Alumis, and Lundbeck drug updates

focus

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

How to bring more disabled researchers into academia

Precocious puberty in girls comes with mental health risks

How to bring more disabled researchers into academia

Amylyx ALS drug failure raises questions and concerns

NEJM study link tiny plastics in blood vessels to heart problems

knowledge

entertainment

entertainment

entertainment